A Phase II, Open-Label Exploratory Study Investigating the Efficacy of Toviaz for Treatment of Adult Patients With Spinal Cord Injury With Neurogenic Detrusor Overactivity for Amelioration of Autonomic Dysreflexia (PIIR-AK-TOVIAZ-AD)
Principal Investigator
Andrei KrassioukovOverview
Study Start/End
Nov 30, 2015 to Jun 30, 2020Locations
GF Strong Rehabilitation Centre, ICORD – Blusson Pavilion, UBC Hospital
Name/Title
Andrea Ramirez, Study CoordinatorPhone
604-675-8856Email Address
aramirez@icord.orgPurpose of Study
This study will be investigating the effects of fesoterodine on autonomic dysreflexia (AD) in patients with spinal cord injuries (SCI). The goal of the study is to examine the effect of increasing daily use of fesoterodine on episodes of high blood pressure triggered by urinary bladder contractions.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.